Market Cap

Shield Therapeutics plc Market Capitalization:

£55.9 Million

GBP as of Jan. 1, 2024

US$71.2 Million

business Shield Therapeutics plc Company Profile

Shield Therapeutics plc Main Stock Listing

LSE: STX

Market Capitalization History of Shield Therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Shield Therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £55.9 M 51.15%
Jan. 1, 2023 £37.0 M -81.53%
Jan. 1, 2022 £200.3 M -33.94%
Jan. 1, 2021 £303.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Shield Therapeutics plc Categories

United Kingdom languages Healthcare languages Drug Manufacturers—Specialty & Generic
United Kingdom Healthcare United Kingdom Drug Manufacturers—Specialty & Generic

Stocks & Indices

Shield Therapeutics plc has the following listings and related stock indices.


Stock: LSE: STX

Stock: FSX: 1JS

Stock: OTC: SHIEF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.